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Abstract
Background: a-TEA (RRR-a-tocopherol ether-linked acetic acid analog), a derivative of RRR-a-tocopherol (vitamin E) exhibits
anticancer actions in vitro and in vivo in variety of cancer types. The objective of this study was to obtain additional insights
into the mechanisms involved in a-TEA induced apoptosis in human breast cancer cells.
Methodology/Principal Findings: a-TEA induces endoplasmic reticulum (ER) stress as indicated by increased expression of
CCAAT/enhancer binding protein homologous protein (CHOP) as well as by enhanced expression or activation of specific
markers of ER stress such as glucose regulated protein (GRP78), phosphorylated alpha subunit of eukaryotic initiation factor
2 (peIF-2a), and spliced XBP-1 mRNA. Knockdown studies using siRNAs to TRAIL, DR5, JNK and CHOP as well as chemical
inhibitors of ER stress and caspase-8 showed that: i) a-TEA activation of DR5/caspase-8 induces an ER stress mediated JNK/
CHOP/DR5 positive amplification loop; ii) a-TEA downregulation of c-FLIP (L) protein levels is mediated by JNK/CHOP/DR5
loop via a JNK dependent Itch E3 ligase ubiquitination that further serves to enhance the JNK/CHOP/DR5 amplification loop
by preventing c-FLIP’s inhibition of caspase-8; and (iii) a-TEA downregulation of Bcl-2 is mediated by the ER stress
dependent JNK/CHOP/DR5 signaling.
Conclusion: Taken together, ER stress plays an important role in a-TEA induced apoptosis by enhancing DR5/caspase-8 pro-
apoptotic signaling and suppressing anti-apoptotic factors c-FLIP and Bcl-2 via ER stress mediated JNK/CHOP/DR5/caspase-
8 signaling.
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Introduction
Targeting cell surface death receptors, especially tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL/Apo2L) binding
receptors, holds promise for cancer treatment [1,2]. TRAIL
selectively induces apoptosis in a wide variety of cancer cells with
little or no toxicity towards normal cells [1,2]. Thus, agents that
can enhance TRAIL death receptor (TRAIL-R/DR4 or TRAIL-
R2/DR5) signaling or sensitize TRAIL resistant cells to TRAIL
induced apoptosis are of interest [2,3]. TRAIL/DR4/DR5
apoptotic signaling includes: interaction of TRAIL with DR4 or
DR5, receptor clustering, recruitment of the adaptor molecule
FADD, and activation of initiator caspases-8 or -10, leading to
cleavage of downstream effector caspases (mitochondrial-indepen-
dent apoptosis) or cleavage of Bid, a pro-apoptotic Bcl-2 family
member, leading to mitochondrial-dependent apoptosis [4].
Evading apoptosis is a hallmark of cancer [5]. One way tumor
cells can escape death signals is by expression of anti-apoptotic
pro-survival proteins [6]. Therefore, targeting anti-apoptotic
proteins also holds promise for killing cancer cells and sensitizing
them to different therapeutics [7]. c-FLIP (cellular FADD-like IL-
1a-converting enzyme inhibitory protein), is a death effector
domain containing protein that regulates extrinsic death receptor
signaling from the tumor necrosis factor-a (TNF-a) family of cell
surface death receptors, including DR4/DR5, Fas (CD95/APO-
1), and TNFR [8]. c-FLIP is a catalytically inactive caspase-8/10
homolog and typically functions as a caspase-8 inhibitor resulting
in chemotherapeutic drug resistance [8].
a-TEA [2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)
chroman-6-yloxyacetic acid], called RRR-a-tocopherol ether-
linked acetic acid analog or RRR-a-tocopheryloxyacetic acid is
a nonhydrolyzable ether analog of RRR-a-tocopherol [9]. a-TEA
has been shown to be a potent pro-apoptotic agent both in vitro
and in vivo in breast, prostate and ovarian cancer cells
[10,11,12,13,14,15]. Recently, a-TEA has been shown to delay
tumor onset and inhibit the progression and metastatic spread in a
clinically relevant model of spontaneous breast cancer, further
highlighting the translational potential of this anticancer agent
[16]. Mechanisms involved in a-TEA induced apoptosis include:
activation of JNK/c-Jun, p73/NOXA and Fas, as well as
PLoS ONE | www.plosone.org 1 July 2010 | Volume 5 | Issue 7 | e11865suppression of c-FLIP-L, survivin and phospho-Akt (pAkt), leading
to death receptor mediated caspase-8 activation and mitochondria
dependent apoptosis [17,18,19,20,21,22,23].
These data are the first to show that a-TEA induces ER stress
dependent increases in death mediators JNK/CHOP/DR5 and
decreases in survival mediators c-FLIP-L and Bcl-2 in human
breast cancer cells. These ER stress mediated events function
downstream of a-TEA triggered TRAIL/DR5/caspase-8 signal-
ing, leading to up-regulation of JNK, CHOP and DR5 and
downregulation of c-FLIP and Bcl-2.
Materials and Methods
Chemicals
a-TEA was made in house as previously described [9]. ER stress
inhibitor salubrinal was purchased from Calbiochem (La Jolla,
CA). Caspase-8 inhibitor Z-IETD-FMK was purchased from
BioVision (Mountain View, CA).
Cell Culture
MDA-MB-231 estrogen-receptor negative human breast cancer
cells were purchased from the American Type Culture Collection
(Manassas, VA). MCF-7 estrogen-responsive human breast cancer
cells were originally provided by Dr. Suzanne Fuqua (Baylor
College of Medicine, Houston, TX). Both cell lines were cultured
in MEM media with 10% FBS. For experiments, FBS was reduced
to 2% and cells were allowed to attach overnight before
treatments. a-TEA (40 mM) was dissolved in ethanol as stock
solution. Equivalent level of ethanol (0.1%) was used as vehicle
control (VEH) for a-TEA treatment (40 mM).
Quantification of apoptosis
Apoptosis was quantified by Annexin V-FITC/PI assay
following the manufacturer’s instructions (Invitrogen).
Western Blot Analyses
Whole cell protein lysates were prepared and western blot
analyses were conducted as described previously [24]. Antibodies
to the following proteins were used: poly (ADP-ribose) polymerase
(PARP), c-FLIP, CHOP, GRP-78, Bcl-2, total JNK, TRAIL and
phospho-JNK (pJNK) (Santa Cruz Biotechnology, Santa Cruz,
CA) and Bid (Pharmigen, Rockville, MD), phospho-eIF-2a
(peIF-2a), eIF-2a (eIF-2a), caspase-8, caspase-9, DR5 and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Cell Sig-
naling Technology, Beverly, MA).
RT-PCR detection of DR5, Bcl-2 and XBP-1 mRNA
expression
Total RNA was extracted using RNA isolation kit (Qiagen Inc.
Valencia, CA). Semi-quantitative analyses were conducted to detect
DR5, Bcl-2 and XBP-1mRNA form by reverse transcriptase
-polymerase chain reaction (RT-PCR) using the housekeeping gene
b-actinas control. 5 mg total RNA was reverse transcribed to cDNA
using 1 ml Superscript RTase (250 U, Invitrogen) following the
manufacture’s instructions. 1 ml cDNA was used per PCR reaction
with 15 ml Taq PCR Master Mix Kit (Qiagen Inc) plus 10 mM
oligonucleotide primer pairs (Invitrogen). Primer sequences are
available upon request.
RNA Interference
A scrambled RNA duplex purchased from Ambion (Austin,
TX) that does not target any of the known genes was used as the
nonspecific negative control for RNAi (referred to as control
siRNA). Transfection of MCF-7 or MDA-MB-231 cells with
siRNA to DR5, TRAIL, CHOP, JNK, Itch or control (Ambion,
Austin, TX) was performed in 100 mm cell culture dishes at a
density of 2610
6 cells/dish using Lipofectamine 2000 (Invitrogen)
and siRNA duplex, resulting in a final siRNA concentration of
30 nM following the company’s instructions. After one day
exposure to transfection conditions, the cells were re-cultured in
100 mm dish at 2610
6 cells/dish and incubated for one day
followed by treatments.
Chromatin immunoprecipiation (ChIP) assay
MDA-MB-231 cells were treated with 40 mMo fa-TEA or
vehicle (0.1% ethanol) for 15 hours. Protein to DNA cross-linking
was conducted by adding 1% formaldehyde to the cell culture
medium for 12 min followed by the addition of glycine (0.125M)
to stop the cross-linking. Cells were collected for ChIP assay as
described by Nelson et al. [25]. The CHOP antibody used for the
Western blot analysis was used for immunoprecipitation. Normal
mouse IgG1 purchased from Santa Cruz Biotechnology was used
as an isotype control. Polymerase chain reaction (PCR) was
conducted using the primers as described by Adbelrahim et al. [26]
to detect CHOP binding sites in the DR5 promoter region.
Ectopic Expression of c-FLIP (L)
Transient transfection of MCF-7 cells with wildtype His-tagged
FLIP expression construct, pcDNA3.1-His-c-FLIP (L), which was
kindly provided by Dr. John C. Reed (The Burnham Inst. La Jolla,
CA) [27] was performed following the procedure published before
[23]. Transfected cells were cultured overnight before a-TEA
treatment.
Statistical Analyses
Apoptosis data were analyzed using a two-tailed student t-test to
determine statistical differences among treatments. Differences
were considered statistically significant at p,0.05.
Results
a-TEA induces TRAIL/DR5 and CHOP dependent
apoptosis
a-TEA treatment of MDA-MB-231 and MCF-7 breast
cancer cells up-regulates DR5 and CHOP protein levels in a
t i m ed e p e n d e n tm a n n e r( F i g1A ) .s i R N Ak n o c k d o w no f
TRAIL, DR5 or CHOP significantly reduces the ability of a-
TEA to induce apoptosis in both cell lines as detected by FACS
analyses of expression of the apoptotic biomarker, Annexin V
(Fig 1 B), suggesting that both TRAIL/DR5 and CHOP are
involved in a-TEA induced apoptosis. Since CHOP has been
shown to act as a positive transcriptional factor for DR5 [28],
s i R N At oC H O Pw a su s e dt oe x a m i n ei fC H O Pr e g u l a t ea-
TEA induced upregulation of DR5. Data show that siRNA to
CHOP reduced the ability of a-TEA to increase CHOP and
DR5 (L/S) levels, as well as to cleave PARP, a biomarker of
apoptosis, in MCF-7 cells (Fig 1C). To further confirm that
DR5 is regulated by CHOP in a-TEA induced apoptosis RT-
PCR to detect mRNA levels of DR5 and ChIP analyses to
assess CHOP binding activity on the DR5 promoter were
conducted in MDA-MB-231 cells. Data show that a-TEA
induces increased levels of DR5 mRNA (Fig 1D) and increased
CHOP binding activity on DR5 promoter (Fig 1E) in
comparison to VEH treated control cells. These data indicate
that CHOP contributes to a-TEA mediated increases in DR5
protein levels and induction of apoptosis.
a-TEA Triggers Apoptosis
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levels are JNK dependent and CHOP influences JNK
phosphorylation status
Since prior studies showed that JNK activation is a critical
component in a-TEA induced apoptosis and other studies have
shown that JNK is involved in upregulation of CHOP protein
expression [29] the possible involvement of JNK in a-TEA
mediated increases in CHOP/DR5 protein expression was
investigated in MCF-7 cells. siRNA to JNK reduced total JNK
and reduced the ability of a-TEA to increase phosphorylated
JNK2/1 (pJNK), increase CHOP and DR5 (L/S) protein levels
and to induce apoptosis as measured by PARP cleavage
(Fig 2A), suggesting that JNK is a critical contributor to
increases in CHOP and DR5 (L/S) protein level. Interestingly,
s i R N At oC H O Pr e d u c e da-TEA mediated increases in
Figure 1. a-TEA induces TRAIL/DR5 and CHOP dependent
apoptosis. A. MDA-MB-231 and MCF-7 cells were treated with 40 mM
a-TEA for 9, 15, and 24 hrs. Western blot analyses were performed to
evaluate DR5 (L/S) and CHOP protein levels using GAPDH as loading
control. B. MDA-MB-231 and MCF-7 cells were transiently transfected
with siRNAs to DR5, TRAIL or CHOP using non-specific siRNA as negative
control followed by treatment with 40 mM a-TEA for 18 hrs. Apoptosis
was determined by Annexin V/FACS. C. Samples (from B) were analyzed
by western blot for PARP cleavage, CHOP and DR5 (L/S) protein levels
using GAPDH as loading control. D. mRNA levels of DR5 were
determined by RT-PCR. E. The binding activity of CHOP on DR5
promoter was determined by CHIP assay. Data from A, C, D and E are
representative of two or more independent experiments. Data from B
are the mean 6 S.D. of three independent experiments. * p,0.05=sig-
nificantly different from control siRNA determined by t-test.
doi:10.1371/journal.pone.0011865.g001
Figure 2. a-TEA induced increased CHOP and DR5 (L/S) protein
levels are JNK dependent. In turn, CHOP regulates pJNK2/1 protein
levels. A. MCF-7 cells were transiently transfected with siRNA to JNK
using non-specific siRNA as negative control followed by treatment
with 40 mM a-TEA for 18 hrs. Western blot analyses were performed to
evaluate PARP cleavage, pJNK2/1, total JNK2/1, CHOP, and DR5 (L/S)
protein levels using GAPDH as loading control. B. MCF-7 cells were
transiently transfected with siRNA to CHOP using non-specific siRNA as
negative control followed by treatment with 40 mM a-TEA for 18 hrs.
Western blot analyses were performed to evaluate pJNK2/1 protein
levels using GAPDH as loading control. Data from A and B are
representative of two or more independent experiments.
doi:10.1371/journal.pone.0011865.g002
a-TEA Triggers Apoptosis
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mediated increases in JNK phosphorylation are dependent on
CHOP expression.
Endoplasmic reticulum stress involvement in a-TEA
induced apoptosis contributes to JNK/CHOP/DR5
upregulation
a-TEA treatment of MDA-MB-231 and MCF-7 cells increased
levels of endoplasmic reticulum stress (ER-stress) indicators:
phosphorylated eukaryotic initiation factor 2-alpha (peIF-2a) and
glucose-regulated protein of 78kDA (GRP78) also known as BiP
(Fig 3A), as well as spliced mRNA forms of X-box binding protein-
1 (XBP-1) (Fig 3B) in a time-dependent manner, suggesting that a-
TEA treatment induced ER stress in both cell lines. Furthermore,
ER-stress inhibitor salubrinal significantly reduced the ability of a-
TEA to induce apoptosis detected by Annexin V/FACS (Fig 3C).
Since JNK/CHOP/DR5 pathway can be activated in response to
ER stress [30], studies were conducted to examine if a-TEA
mediated JNK/CHOP/DR5 (L/S) signaling events via ER stress.
Data show that ER-stress inhibitor salubrinal significantly reduced
the ability of a-TEA to upregulate pJNK2/1, CHOP, and DR5
(L/S), as well as to induce PARP cleavage in both cell lines
(Fig. 3D). Salubrinal significantly reduced the ability of a-TEA to
upregulate ER stress markers GRP78 and peIF2a, confirming the
efficiency of ER-stress inhibitor. These data demonstrate that a-
TEA induction of JNK/CHOP/DR5 and apoptosis is mediated
via ER stress.
a-TEA induction of ER stress-dependent JNK/CHOP/DR5
signaling is mediated by TRAIL/DR5 pathway
Since both JNK and DR5 can be regulated by TRAIL/DR5
signaling [30,31], studies were conducted to determine if a-TEA
mediated ER stress events are downstream events of TRAIL/DR5
using siRNA knockdown procedures. MCF-7 and MDA-MB-231
cells transiently transfected with siRNAs to DR5 or TRAIL
exhibited reduced levels of DR5 and TRAIL, respectively, and
showed blockage of a-TEA’s ability to produce PARP cleavage
and to increase levels of pJNK2/1, CHOP, DR5 (L/S), as well as
blocked a-TEA’s ability to upregulate ER stress markers GRP78
and peIF-2a (Fig 4 A, B & C), demonstrating that a-TEA
induction of ER stress-dependent JNK/CHOP/DR5 signaling is
mediated by TRAIL/DR5 pathway.
ER stress dependent JNK/CHOP/DR5 upregulation occurs
both upstream and downstream of caspase-8 activation
In an effort to determine if ER stress proceeds or follows a-TEA
activation of DR5 signaling, caspase-8 inhibitor (Z-IETD-FMK)
was employed. Data show that caspase-8 inhibitor significantly
reduced a-TEA abilities to induce apoptosis (Fig 5A), and cleavage
of Bid, caspase-9 and PARP, as well as increase protein levels of
pJNK2/1, CHOP, DR5, and ER stress markers GRP78 and peIF-
2a in both cell types (Fig 5B). These data suggest that a-TEA
activation of caspase-8 is upstream of ER-stress mediated JNK/
CHOP/DR5 signaling. siRNA knockdown of JNK, CHOP and
DR5 in MCF-7 cells reduced the ability of a-TEA to cleave
caspases 8 and 9 (Fig 5 C), suggesting that not only DR5 but also
JNK and CHOP are involved in activation of caspases-8 and -9.
Furthermore, treatment of MDA-MB-231 and MCF-7 cells with
ER inhibitor salubrinal blocked a-TEA’s ability to induce
caspases-8 and -9 cleavage (Fig 5 D), providing additional
evidence for caspase 8 acting prior to and after a-TEA induced
ER stress.
Figure 3. ER stress is involved in a-TEA induced apoptosis and
contributes to JNK/CHOP/DR5 upregulation. A. MDA-MB-231 and
MCF-7 cells were treated with 40 mM a-TEA for 9, 15, and 24 hrs. Western
blot analyses were performed to determine ER stress markers; peIF-2a,
total eIF2a and GRP78 protein levels. GAPDH levels were used as lane
controls. B. Splicing of XBP-1, a marker for ER stress, was determined by RT-
PCR. C. Both cell lines were treated with ER-stress inhibitor salubrinal at
40 mMp l u s40mMa-TEAfor18 hrs.Apoptosiswasdeterminedby Annexin
V/FACS. D. Western blotting was conducted to evaluate salubrinal effects
on a-TEA induced cleavage of PARP, upregulation of pJNK/2/1, CHOP, DR5
(L/S), peIF2a,t o t a le I F 2 a, and GRP78 proteins. Data from A, B and D are
representative of at least 2 individual experiments. Data from C are
presented as the mean 6 S.D. of three independent experiments.
* P,0.05= ER-stress inhibitor salubrinal at 40 mMp l u s4 0 mM a-TEA
treatment is significantly different from 40 mM a-TEA determined by t-test.
doi:10.1371/journal.pone.0011865.g003
a-TEA Triggers Apoptosis
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part, mediated by caspase-8/ER stress/JNK/CHOP/DR5
signaling via Itch E3 ligase ubiquitination
a-TEA downregulates c-FLIP (L) protein levels in both MDA-
MB-231 and MCF-7 breast cancer cells in a time dependent
manner (Fig 6A). MCF-7 cells transiently transfected with siRNA to
CHOP, JNK or DR5, and both MDA-MB-231 and MCF-7 cells
cultured withER-stress inhibitorsalubrinal orcaspase 8 inhibitor Z-
IETD-FMK prevented the ability of a-TEA to decrease c-FLIP (L)
protein levels (Fig 6B and C), providing evidence that a-TEA
downregulation of c-FLIP is mediated by caspase-8/ER stress/
JNK/CHOP/DR5 signaling. Since c-FLIP has been reported to be
degraded via JNK-dependent E3 ubiquitin ligase Itch [32], studies
were conducted to determine if Itch E3 ligase mediated ubiquitina-
tion was involved in a-TEA down-regulation of c-FLIP. Knock-
down of Itch E3 ligase with siRNA to Itch reduced a-TEA’s ability
to downregulate c-FLIP (L) protein levels in MCF-7 cells (Fig. 6D).
siRNA to Itch significantly reduced the ability of a-TEA to induce
apoptosis in MDA-MB-231 and MCF-7 cells (Fig 6E). These data
suggest that a-TEA induced downregulation of c-FLIP (L) is
mediated by a caspase-8/ER stress/JNK/CHOP/DR5 pathway
via Itch ligase ubiquitination.
Figure 4. ER stress dependent JNK/CHOP/DR5 upregulation is mediated by TRAIL/DR5 pathway in a-TEA induced apoptosis. A&B .
MCF-7 cells were transiently transfected with siRNA to DR5 or TRAIL, using non-specific siRNA as negative control followed by treatment with 40 mM
a-TEA for 18 hrs. Western blot analyses were performed to evaluate PARP cleavage, pJNK2/1, CHOP, DR5 (L/S), peIF-2a total eIF-2a and GRP78 protein
levels, using GAPDH as loading control for (A & B) and TRAIL protein levels for siRNA knockdown efficiency (B). C. MDA-MB-231 cells were transiently
transfected with siRNA to DR5 or TRAIL, using non-specific siRNA as negative controls followed by treatment with 40 mM a-TEA for 18 hrs. Western
blot analyses were performed to evaluate PARP cleavage, pJNK (2/1), CHOP, DR5 (L/S), peIF-2a, GRP78, and TRAIL protein levels, using GAPDH as
loading control. Data from A, B and C are representative of at least 2 individual experiments.
doi:10.1371/journal.pone.0011865.g004
a-TEA Triggers Apoptosis
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dependent JNK/CHOP/DR5 signaling via activation of
caspase-8
Since c-FLIP is an inhibitor of caspase-8 activation, we
hypothesized that a-TEA downregulation of c-FLIP may contrib-
ute to activation of caspase-8 and subsequent ER stress-dependent
JNK/CHOP/DR5 signaling. To test this hypothesis, MCF-7 cells
were transiently transfected with wildtype c-FLIP (L) plasmid or
Itch siRNA followed by treatment with a-TEA (40 mM) for 18 hrs.
Over-expression of c-FLIP enhanced c-FLIP (L) levels (Fig 6G)
and siRNA to itch blocked a-TEA’s ability to reduce c-FLIP
protein expression (Fig 6D). Both overexpression of c-FLIP (L)
protein and restoration of c-FLIP protein expression by silencing
itch in a-TEA treatment reduced the ability of a-TEA to cleave
PARP and caspase-8, and to increase protein levels of pJNK2/1,
CHOP, DR5, and GRP 78 (Fig 6G and H). These data suggest
that a-TEA’s ability to downregulate c-FLIP (L) is important for
caspase-8 activation and subsequent activation of the ER stress/
JNK/CHOP/DR5 signaling.
a-TEA downregulation of Bcl-2 protein and mRNA
expression is mediated by ER stress
a-TEA treatment of MDA-MB-231 and MCF-7 cells reduced
both Bcl-2 protein and mRNA levels in a time dependent manner
(Fig 6A and F). siRNA to JNK, CHOP, and DR5 (Fig 6B) as well
as caspase-8 and ER stress inhibitors (Fig 6C) blocked the ability of
a-TEA to decrease Bcl-2 protein expression. These data suggest
that a-TEA induced down-regulation of Bcl-2 is mediated by
caspase-8, ER stress, JNK, CHOP and DR5.
Discussion
The underlying mechanisms of how a-TEA, a potential
chemotherapeutic drug, enhances DR5 death signaling path-
ways were investigated. For the first time, studies demonstrate
that: (i) a-TEA induces ER stress dependent apoptosis, (ii) a-
TEA induced ER stress regulates JNK/CHOP/DR5 signaling
a n di sm e d i a t e db yT R A I L / D R 5 / c a s p a s e - 8 ,f o r m i n gap o s i t i v e
loop, (iii) a-TEA downregulation of c-FLIP is mediated by ER
stress-dependent JNK/CHOP/DR5 signaling via JNK activa-
tion of Itch E3 ligase ubiquitination and involved in activation
of the ER-stress-dependent events via reducing the inhibitory
effect of c-FLIP on caspase-8, and (iv) a-TEA downregulation of
Bcl-2 protein levels is mediated by the ER stress-dependent
events. Taken together, these data show that a-TEA induces
TRAIL/DR5/caspase-8 dependent ER stress that triggers
JNK/CHOP/DR5 signaling enhancing DR5/caspase-8 medi-
ated mitochondria-dependent apoptotic signaling and produces
a downregulation of two key anti-apoptotic factors; c-FLIP and
Bcl-2. Based on these data, we provide a schematic diagram
depicting a series of events including a positive-acting feedback
loop, which is operative in a-TEA induced DR5 dependent
apoptosis of human breast cancer cells in culture (Fig 7). DR5
signaling triggers caspase-8 activation, leading to two a-TEA
initiated pathways: (i) a classic mitochondria-dependent apo-
ptotic cascade initiated by cleavage of Bid and (ii) an ER-stress
dependent activation of JNK/CHOP/DR5 sequence leading to
further activation of caspase-8 and downregulation of anti-
apoptotic factors; c-FLIP and Bcl-2. Importantly, down-
regulation of c-FLIP serves to further enhance caspase-8
activation, which sustains the ER-stress/JNK/CHOP/DR5
amplifying loop.
TRAIL has emerged as a potent anticancer agent based on its
ability to induce apoptosis in tumor cells but not in most normal
cells [1,2,3]. Thus, targeting TRAIL/DR4/DR5 signaling
pathways holds promise for inducing pro-apoptotic signaling
in many cancer types while sparing normal cells and tissues
[33,34]. Although considerable effort has been made in
investigating the biological ramifications of TRAIL death
receptor signaling, a complete understanding of the multiple
pathways and events involved remain unclear. Typically,
signaling pathways that initiate apoptosis have been broadly
classified as (i) extrinsic death receptor initiated pathways or (ii)
intrinsic pathways initiated by mitochondrial events [35]. These
two pathways are not mutually exclusive, and JNK and caspase-
8h a v eb e e no b s e r v e dt op l a yc e n t r a lr o l e si nb o t h[ 4 , 3 6 ] .O u r
findings that TRAIL/DR5/casapse-8 triggers an ER stress
dependent JNK/CHOP/DR5 amplifying loop and a JNK/c-
FLIP/caspase-8 amplifying loop in a-TEA induced apoptosis
provides new insights into TRAIL/DR5-mediated apoptotic
signaling.
DR5 upregulation has been reported to be mediated by NF-kB
in TRAIL- induced apoptosis in MCF-7 and MDA-MB-231 cells
[37]. However, inhibition of NF-kB using IkB phosphorylation
inhibitor BAY-11-7085 [38] enhances a-TEA induced upregula-
tion of DR5 and apoptosis in MCF-7 cells (data not shown),
suggesting that NF-kB plays an anti-apoptotic role in a-TEA-
induced apoptosis. Data reported here showing that a-TEA up-
regulates DR5 via CHOP binding to the DR5 promoter is
supported by published reports showing that CHOP can directly
regulate DR5 expression through a CHOP binding site in the 59-
flanking region of the DR5 promoter [28,39].
JNK is a stress responsive kinase that has been reported to
induce CHOP expression via an AP-1 binding site in the CHOP
promoter [40,41]. JNK has been shown to be activated and is
required for a-TEA-induced apoptosis of human breast, ovarian
and prostate cancer cells [17,18,19,20]. Data presented here show
that siRNA to JNK blocks a-TEA induced CHOP as well as DR5,
indicating that CHOP/DR5 upregulation is mediated via JNK in
a-TEA induced apoptosis. These data are in agreement with other
studies showing that CHOP is an ER stress-regulated protein [42],
JNK activation can contribute to CHOP expression during ER
stress [43], and coupling of JNK/CHOP/DR5 are involved in ER
stress-mediated apoptosis [29].
Present study show that a-TEA induces increased levels of
peIF-2a and GRP78 proteins and spliced XBP-1, all of which are
Figure 5. ER stress-dependent JNK/CHOP/DR5 upregulation is both upstream and downstream events of caspase-8. A. MDA-MB-231
and MCF-7 cells were cultured with caspase-8 inhibitor (Z-IETD-FMK) or DMSO vehicle control plus 40 mM a-TEA for 18 hrs. Apoptosis was determined
by Annexin V/FACS. B. Samples (from A) were analyzed by western blot to evaluate caspase-8 cleavage of Bid to tBid, cleaved caspase 9 and PARP,
pJNK2/1, CHOP, DR5 (L/S), peIF-2a and GRP78 protein levels using GAPDH as loading control. C. MCF-7 cells were transiently transfected with siRNA
to JNK, CHOP and DR5, using non-specific siRNA as negative control followed by treatment with 40 mM a-TEA for 18 hrs. Western blot analyses were
performed to evaluate caspase-8 and -9 cleavages, GAPDH served as lane controls. D. MDA-MB-231 and MCF-7 cells were cultured with ER-stress
inhibitor salubrinal at 40 mM plus 40 mM a-TEA for 18 hrs. Western blot was conducted to evaluate caspase-8 and -9 cleavages, GAPDH served as lane
controls. Data from B, C and D are representative of two or more individual experiments. Data from A are presented as the mean 6 S.D. of three
independent experiments. * P,0.05= caspase-8 inhibitor (Z-IETD-FMK) at 2 mM plus 40 mM a-TEA treatment is significantly different from 40 mM a-
TEA determined by t-test.
doi:10.1371/journal.pone.0011865.g005
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PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e11865Figure 6. a-TEA decreased Bcl-2 and c-FLIP (L) protein levels via caspase-8 dependent ER stress-mediated JNK/CHOP/DR5
pathway. A. MDA-MB-231 and MCF-7 cells were treated with 40 mM a-TEA for 9, 15, and 24 hrs. Western blot analyses were performed to
evaluate Bcl-2 and c-FLIP (L) protein levels with GADPH as loading control. B. MCF-7 cells were transiently transfected with JNK, CHOP, and DR5
siRNA or control siRNA followed by treatment with 40 mM a-TEA or vehicle for 18 hrs. Bcl-2 and c-FLIP (L) protein levels were determined by
western blot analyses, using GAPDH as loading control. C. MDA-MB-231 and MCF-7 cells were cultured with ER-stress inhibitor salubrinal at 40 mM
or caspase-8 inhibitor (Z-IETD-FMK) at 2 mMp l u s4 0mM a-TEA for 18 hrs. Bcl-2 and c-FLIP (L) protein levels were determined by western blot
analyses, using GAPDH as loading control. D. MCF-7 cells were transiently transfected with Itch siRNA or control siRNA followed by treatment with
40 mM a-TEA or vehicle for 18 hrs. c-FLIP (L) protein levels were determined by western blot analyses. E. MDA-MB-231 and MCF-7 cells were
transiently transfected with siRNA to itch using non-specific siRNA as negative control followed by treatment with 40 mM a-TEA for 18 hrs.
Apoptosis was determined by Annexin V/FACS. F. MDA-MB-231 and MCF-7 cells were treated with 40 mM a-TEA for 9, 15, and 24 hrs. mRNA levels
of Bcl-2 were determined by RT-PCR G. MCF-7 cells were transiently transfected with wild-type c-FLIP plasmid or vector control followed by
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PLoS ONE | www.plosone.org 8 July 2010 | Volume 5 | Issue 7 | e11865recognized as ER stress markers [44,45] and that salubrinal, a
selective inhibitor of eIF-2a dephosphorylation (protects cells
from ER stress) [46] blocked a-TEA induced apoptosis and the
ability of a-TEA to activate JNK/CHOP/DR5 and upregulate
ER stress markers, confirming that ER stress is induced by a-
TEA and is involved in both apoptosis and activation of JNK/
CHOP/DR5.
Present data show that a-TEA induction of the ER stress
dependent JNK/CHOP/DR5 pathway is a downstream conse-
quence of TRAIL/DR5 signaling. Furthermore, a caspase-8
inhibitor not only blocks a-TEA induced mitochondria-depen-
dent apoptotic cascade as indicated by blockage of Bid and pro-
caspase-9 cleavage, but also blocks ER stress signaling events,
indicating that TRAIL/DR5 downstream effector caspase-8
contributes to a-TEA induced ER stress-dependent events. To
our knowledge, this is the first report that ER stress can be
triggered by a TRAIL/DR5/caspase-8 pathway and that ER
stress induces a JNK/CHOP/DR5 amplifying loop that can
further enhance TRAIL/DR5-mediated apoptosis. The mecha-
nism(s) whereby activated caspase-8 induces ER stress were not
investigated in this study. However, studies using hepatoblastoma
HepG2 cells suggest that activated caspase-8 may promote and
amplify the ER stress response by cleaving BAP31, an integral
membrane protein of the ER, in glycochenodeoxycholic acid-
induced apoptosis [47].
As a caspase-8 inhibitor, c-FLIP plays an important role in
death receptor dependent apoptosis. Published data showed that
down-regulation of c-FLIP is involved in a-TEA induced
apoptosis in human ovarian and prostate cancer cells
[18,22,23]. However, how a-TEA regulates c-FLIP is not known.
Data reported here show that down-regulation of c-FLIP is
mediated by the caspase-8 dependent ER stress JNK/CHOP/
DR5 loop via JNK-mediated phosphorylation and activation of
the E3 ubiquitin ligase Itch. JNK-mediated protein degradation
of c-FLIP has been reported for TNF-induced cell death [48].
However, it is the first report that JNK-mediated c-FLIP
degradation is ER stress dependent.
Bcl-2 is a well established anti-apoptotic factor, which
inhibits mitochondrial dependent apoptosis. It has been
reported that ER stress induces downregulation of Bcl-2 via
CHOP [49]. Although CHOP is a transcription factor, a
CHOP responsive site in the Bcl-2 promoter has not been
reported; suggesting that if CHOP mediates transcriptional
regulation of Bcl-2 expression it must form a complex with
other proteins [49]. Here, for the first time, we demonstrate
that a-TEA downregulates Bcl-2 at both protein and mRNA
levels, which is regulated by ER-stress mediated JNK/CHOP/
DR5 signaling.
In conclusion, data show that a-TEA induces a TRAIL/DR5/
caspase-8 dependent ER stress-mediated JNK/CHOP/DR5 loop,
which amplifies caspase-8-mediated mitochondrial-dependent
apoptosis via downregulation of c-FLIP and Bcl-2. These data
are significant in that they provide a better understanding of the
pro-apoptotic actions of the anti-cancer agent a-TEA, and provide
new insights into DR5-mediated apoptotic signaling in human
breast cancer cells.
treatment with 40 mM a-TEA for 18 hrs. Western blot analyses were performed to evaluate over expression of c-FLIP on ability of a-TEA to cleave
PARP and caspase-8, and down-regulate c-FLIP (L), pJNK2/1, CHOP, DR5 (L/S), peIF-2a and GRP78 protein expression using GAPDH as loading
control. H. MCF-7 cells were transiently transfected with siRNA to Itch, using non-specific siRNA as negative control followed by treatment with
40 mM a-TEA for 18 hrs. Western blot analyses were performed to evaluate elevated levels of c-FLIP (L) on ability of a-TEA to cleave PARP and
caspase-8 and to down-regulate pJNK2/1, CHOP, DR5 (L/S) and GRP78 protein levels using GAPDH as loading control. Data for A, B, C, D, F, G and
H are representative of two or more individual experiments. Data from E are the mean 6 S.D. of three independent experiments.
*p ,0.05=significantly different from control siRNA determined by t-test.
doi:10.1371/journal.pone.0011865.g006
Figure 7. Schematic diagram showing a-TEA to induce breast cancer cells to undergo apoptosis via caspase-8 mediated ER stress
JNK/CHOP/DR5 amplification loop and by down-regulation of anti-apoptotic mediators c-FLIP (L) and Bcl-2.
doi:10.1371/journal.pone.0011865.g007
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